Gain Your Inhibitions

Today, we enter happily into the secret world (as far as NICE is concerned) of SGLT2 inhibitors. These clever drugs increase glucose excretion by the kidney thereby reducing blood glucose levels. When manufacturers produce new drugs …

Read More

Me Too!

As long as manufactured goods have been around, “me-too” preparations have been around.  When a successful thing is introduced, competitors produce a similar one, but sufficiently different not to infringe patent laws. When Renault introduced the …

Read More

Statins Again

It is difficult to remember any time in the past when the British Medical Journal has withdrawn information in any articles it has published and yet this has now happened in the case of two articles …

Read More

A dose of your own medicine

One of our friends is in the terminal phase of cancer. He was suffering quite a lot of pain so he was seen by one of the truly wonderful MacMillan Nurses. The nurse decided to give …

Read More

Trial behind closed doors?

“An MP’s Committee has warned that drugs companies routinely withhold results of clinical trials from doctors, leaving them poorly informed about how to treat patients” This report from the Public Accounts Committee arose as a result …

Read More

Me Too!

The long term management of COPD has been affected by the latest “me-too” drug to be announced.  Until now the only long-acting anti-muscarinic drug available was tioptropium. Until now, Boehringer-Ingelheim have had this important field to …

Read More